ABCD2 Score Calculator for TIA
Calculate the ABCD2 score for stroke risk after a TIA. Instant 2-day risk band, the dual antiplatelet threshold used in CHANCE and POINT, and the workup that is warranted at every score.
Reviewed by Zaka Ahmed, MD Clinical reference · 6 min read
ABCD2 Score Calculator
Select every item as assessed at presentation. Nothing is preselected, so a zero-point answer stays distinct from an item you have not scored yet.
Score every item to see the risk band and what it implies.
What the score does and does not change
Educational tool only. ABCD2 is one input among many; it does not decide disposition and does not replace clinical judgment or in-person evaluation. If symptoms are happening now, call emergency services. Risk estimates from Johnston et al., Lancet 2007 (validation cohorts).1
Clinical notes & interpretation Scoring guidance, pitfalls, FAQs, and references
The ABCD2 score puts a number on early stroke risk after a TIA — useful for flagging a high-risk group, unsafe as a discharge rule.
- → Five bedside factors give a total of 0–7; higher totals tracked with higher 2-day stroke risk in the original cohort.
- → A score of 4 or more is part of the high-risk definition CHANCE and POINT used when enrolling patients for short-course dual antiplatelet therapy.
- → The workup does not change with the score: every suspected TIA warrants urgent brain imaging, vessel imaging, and rhythm assessment.
A TIA is a warning delivered in the only language the brain has. The symptoms resolve; the risk does not. ABCD2 was built to size that risk in the minutes after the patient arrives, from things you already have — an age, a blood pressure, what the deficit was, how long it lasted, and whether they have diabetes.1
At a glance · what the score changes
- 0–3 · roughly 1% stroke risk within 2 days in the original validation cohorts. Not a discharge criterion — later cohorts found the score discriminates inconsistently, and strokes occur in this band.
- 4–5 · roughly 4%. 6–7 · roughly 8% — close to 1 in 12 at the top of the range.
- At 4 or more, the patient meets the ABCD2 component of the high-risk definition CHANCE and POINT used to enrol patients for short-course dual antiplatelet therapy, started early after the event.
- Course length matters. POINT showed major bleeding rises when the combination is carried on too long, which is why guideline-recommended courses are short rather than indefinite.
- At any score, urgent brain imaging, imaging of the neck and intracranial vessels, and rhythm assessment are warranted. Carotid stenosis, atrial fibrillation and a cardiac clot source carry high recurrence risk wherever the number lands.
The five components
- A — Age: 60 years or older = 1 point.
- B — Blood pressure: systolic ≥ 140 mm Hg or diastolic ≥ 90 mm Hg at presentation = 1 point.
- C — Clinical features: unilateral weakness = 2 points; speech disturbance without weakness = 1 point; neither = 0.
- D — Duration: 60 minutes or longer = 2 points; 10–59 minutes = 1 point; under 10 minutes = 0.
- D — Diabetes: present = 1 point.
Everything on that list is available within minutes of arrival — a history, a cuff, and a quick exam. That is why the score spread through emergency departments as fast as it did.
Risk by band
- 0–3: roughly 1% stroke risk within 2 days.
- 4–5: roughly 4% within 2 days.
- 6–7: roughly 8% within 2 days.
The same climbing pattern held at 7 and 90 days.1 The shape of the curve is the useful part; the exact percentages come from cohorts that predate current secondary-prevention practice.
Pitfall
Using ABCD2 as an admit-or-discharge rule is where this score does harm. External validation has been inconsistent, and the causes that drive early recurrence — tight carotid stenosis, atrial fibrillation, a cardiac clot source — are exactly the ones the score does not measure. A patient with a score of 2 and a 90% carotid stenosis is not low risk.
Where it still earns its keep
Selecting candidates for short-course dual antiplatelet therapy. CHANCE and POINT both used an ABCD2 of 4 or more as part of the high-risk definition when enrolling patients with TIA or minor ischemic stroke, and both found that a brief course of aspirin plus clopidogrel reduced early recurrent stroke compared with aspirin alone.23 POINT also showed the cost of carrying the combination too long — more major bleeding — which is why current AHA/ASA secondary-prevention guidance frames it as a short course started early in selected patients.4
That is the score doing what it is good at: flagging a group, not making a decision. For sharper discrimination of 7-day risk, the Canadian TIA Score adds the mechanisms ABCD2 leaves out — atrial fibrillation, carotid disease, infarction on CT. The longer discussion of how ABCD2 has held up since 2007 is in the full ABCD2 review.
If you are a patient reading this
TIA symptoms that went away are still an emergency. Sudden weakness or numbness on one side, trouble speaking or understanding, a drooping face, vision loss, or sudden severe imbalance — even lasting only minutes — means calling emergency services (911 in the US), not calculating a score at home. Risk is highest in the first days, which is exactly when evaluation changes the outcome.
Frequently asked questions.
What does ABCD2 stand for?
Age, Blood pressure, Clinical features, Duration of symptoms, and Diabetes. The five components add to a total from 0 to 7.
What is a high ABCD2 score?
In the original validation, 6–7 was the high-risk band, with roughly an 8 percent risk of stroke within 2 days. A score of 4 or more is the threshold more often used in practice, because CHANCE and POINT used it to define the high-risk group eligible for short-course dual antiplatelet therapy.
Does a low ABCD2 score mean the patient can be sent home?
No. The score should not decide disposition on its own. Later cohorts found its discrimination inconsistent, and it does not capture carotid stenosis, atrial fibrillation, or a cardiac clot source — causes that carry high early recurrence risk at any score.
How does ABCD2 relate to dual antiplatelet therapy?
CHANCE and POINT enrolled patients with high-risk TIA or minor stroke, using an ABCD2 of 4 or more as part of that definition, and showed a reduction in early recurrent stroke with a short course of aspirin plus clopidogrel. Guidelines reflect this for selected patients started early after the event; the course is deliberately short because prolonged dual therapy increases major bleeding.
Can I calculate my own ABCD2 score at home?
The components are simple, but the score is a clinician's tool used alongside imaging and rhythm monitoring. Anyone with TIA-like symptoms should call emergency services rather than self-assess.
References.
- Johnston SC, Rothwell PM, Nguyen-Huynh MN, et al. Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack. Lancet. 2007;369(9558):283–292. PubMed
- Wang Y, Wang Y, Zhao X, et al. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack (CHANCE). N Engl J Med. 2013;369(1):11–19. PubMed
- Johnston SC, Easton JD, Farrant M, et al. Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA (POINT). N Engl J Med. 2018;379(3):215–225. PubMed
- Kleindorfer DO, Towfighi A, Chaturvedi S, et al. 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association. Stroke. 2021;52(7):e364–e467. PubMed